Evidence map›Paper›PMID 28452565›Full record

ArticleJournal of medicinal food2017

Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.

Bo-Kyung Park, Eunho Chun, Jeong June Choi, Younmin Shin, Young Tak Kho, Seung Hyun Oh, Sun Yeou Kim, Taek Hwan Lee, Tae-Wan Kim, Eunju Shin and 2 more

Abstract read
In one paragraph

Article in Journal of medicinal food, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Nutrients · 2024
    Article
  3. Review
  4. Article
  5. Wasabi (Foods (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antidepressant-Like Effects ofBioMed research international · 2018
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bo-Kyung Park1 KM Convergence Research Division, Korea Institute of Oriental Medicine , Daejeon, South Korea .
Eunho Chun2 College of Korean Medicine, Daejeon University , Daejeon, South Korea .
Jeong June Choi2 College of Korean Medicine, Daejeon University , Daejeon, South Korea .
Younmin Shin2 College of Korean Medicine, Daejeon University , Daejeon, South Korea .
Young Tak Kho3 College of Pharmacy, Gachon University , Incheon, South Korea .
Seung Hyun Oh3 College of Pharmacy, Gachon University , Incheon, South Korea .
Sun Yeou Kim3 College of Pharmacy, Gachon University , Incheon, South Korea .
Taek Hwan Lee4 College of Pharmacy, Yonsei University , Incheon, South Korea .
Tae-Wan Kim5 Department of Physiology, College of Veterinary Medicine, Kyungpook National University , Daegu, South Korea .
Eunju Shin6 Life Science Research Institute Univera, Inc. , Seoul, South Korea .
Seon-Gil Do6 Life Science Research Institute Univera, Inc. , Seoul, South Korea .
Mirim Jin7 College of Medicine, Gachon University , Incheon, South Korea .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) is a functional gastrointestinal disease with complex pathophysiology involving the brain-gut axis. To assess the effects of Wasabia koreana (WK) on IBS, we employed a mouse model of colonic zymosan injection presenting with diarrhea-predominant IBS-like symptoms. Oral WK administration significantly diminished stool score, suppressed colon length and weight change, and minimized body weight loss without affecting food intake. In WK-treated mice, the submucosal thickening and epithelial lining of the colon were inhibited and were similar to those of naïve mice. Infiltration of mast cells into the colon and serum tumor necrosis factor-α levels were markedly suppressed. These effects were comparable to those of sulfasalazine, an anti-inflammatory drug. Furthermore, the number of visceral pain-related behaviors was significantly decreased, and locomotion activities measured in the elevated plus maze and open field tests were significantly increased by WK in a dose-dependent manner compared with amitriptyline, an antidepressant. These changes were accompanied by reduced FosB2 expression in the brain. Taken together, these data suggest that WK may have potential as a medicinal food for IBS by acting on inflammatory diarrhea and neural activity.

Indexed as

AnimalsColonDisease Models, AnimalHumansIrritable Bowel SyndromeMaleMiceMice, Inbred C57BLPlant ExtractsTumor Necrosis Factor-alphaWasabiaZymosanPlant ExtractsTumor Necrosis Factor-alphaZymosananimal modelanxietycolonic inflammationdiarrhea-predominant irritable bowel syndromepainwasabizymosan

Identifiers

PMID28452565
PMCPMC5444489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.